IP Library Patent Application 14200126
Patent Application
App. No. 14/200,126

AEROSOL CONTAINER FOR FOAMABLE COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/200,126
Abstract

A composition and therapeutic kit provide a therapeutic azole with increased solubility. The kit includes an aerosol packaging assembly containing a container accommodating a pressurized product and an outlet capable of releasing the pressurized product as a foam. The pressurized product includes a foamable composition including: i. a therapeutic azole, wherein the solubility of the azole in the composition before foaming is less than the solubility of the azole in the composition after foaming; ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a co-solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight; iii. a surface-active agent; iv. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; v. water; and vi. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.

Claims (16)

1 . (canceled)

2 . An aerosol container comprising a pressurized product and an outlet capable of releasing the pressurized product as a foam;

wherein said pressurized product comprises a foamable composition comprising:

i. a therapeutic azole, wherein the solubility of the azole in the composition before foaming is less than the solubility of the azole in the composition after foaming;

ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a co-solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight;

iii. a surface-active agent;

iv. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent;

v. water; and

vi. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.

3 . The container of claim 2 , wherein the outlet comprises a valve.

4 . The container of claim 3 , wherein the valve comprises a stem with at least 1 aperture formed in said stem.

5 . The container of claim 4 , wherein the valve comprises a stem with 1 to 4 apertures formed in said stem.

6 . The container of claim 4 , wherein each said aperture formed in said stem has a diameter of about 0.2 mm to about 1 mm.

7 . The container of claim 4 , wherein each said aperture formed in said stem has a diameter of about 0.3 mm to about 0.8 mm.

8 . The container of claim 4 , wherein the sum of areas of all apertures in said stem is between about 0.01 mm2 and 1 mm2.

9 . The container of claim 4 , wherein the sum of areas of all apertures in said stem is between about 0.04 mm2 and 0.5 mm2.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE PHARMACEUTICALS LTD. (F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0980 →
PATENT SECURITY AGREEMENT Recorded Mar 9, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0966 →
CHANGE OF NAME Recorded Jul 30, 2014
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS LTD.
Reel/Frame 033445/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: TAMARKIN, DOV; FRIEDMAN, DORON; EINI, MEIR
To: FOAMIX LTD.
Reel/Frame 032729/0285 →